Papers: 10.3390/cancers13123101

https://doi.org/10.3390/cancers13123101

Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study

Cited by: 3
Author(s): B.M. Berger, Andrea Thueringer, Doritt Franz, Nadia Dandachi, Emina Talakić, Georg Richtig, Erika Richtig, Peter Michael Rohrer, Lukas Koch, Ingrid Wolf, Catharina Koch, Barbara M. Rainer, Maximilian Koeller, Martin Pichler, Hanno Gerritsmann, Karl Kashofer, Ariane Aigelsreiter
Published: over 5 years ago

Software Mentions 1